🟢 Edesa Biotech is trading 6% up in after-hours trading after August 20 offering pricing

Edesa Biotech is trading at $4.67, up +6.14%, after rebounding from recent selling tied to its August 20, 2026, $25 million underwritten offering.

• Financing includes common shares, pre-funded warrants, and warrants, priced at $5.50 per common-share unit; gross proceeds are expected to approximate $25 million.
• The company’s official news page lists the offering pricing as its latest release, with no newer August 24 company announcement identified.